Louise C. Showe is an American researcher who is scientific director of the Genomics Facility and the Bioinformatics Facility at The Wistar Institute in Philadelphia.[1][2][3] Her research focuses on functional genomics and how they can be used to better understand the immune system and cancer.
Showe has said that being able to "globally screen gene expression patterns using genomics and proteomics appears to have injected a new level of enthusiasm for learning what is going on in complex cancers that have been particularly recalcitrant to therapy."[4] Recently, Showe's research led to the creation of a blood test that could be used to test for lung cancer using a 29-gene assay.[5] The company OncoCyte has partnered with Wistar to develop lung cancer diagnostic tests.[6]
References
edit- ^ "Louise C. Showe, Ph.D." The Wistar Institute. Retrieved 18 February 2014.
- ^ "Louise C. Showe". The University of Pennsylvania. Retrieved 18 February 2014.
- ^ "Wistar establishes research center for advanced biology studies". Philadelphia Business Journal. Retrieved 18 February 2014.
- ^ "Benefiting from the Human Genome". The Scientist. Retrieved 18 February 2014.
- ^ "Health: Local Researchers Developing Lung Cancer Blood Test". CBS Philly. Retrieved 18 February 2014.
- ^ "BioTime's Subsidiary OncoCyte Corporation and The Wistar Institute To Collaboratively Develop Cancer Diagnostics". BioTime Inc. Retrieved 18 February 2014.
External links
edit
   | This biographical article related to medicine in the United States is a stub. You can help Wikipedia by expanding it. |